Eliquis Oral Tablet 2.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Eliquis: Oral tablet (2.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_17064.JPG
Eliquis 2.5mg Tablet
Bristol Myers Squibb Co
Pill Identification: 893  |  2 1/2

What is this Medicine?

APIXABAN (a PIX a ban) is an anticoagulant (blood thinner). It is used to lower the chance of stroke in people with a medical condition called atrial fibrillation. It is also used to treat or prevent blood clots in the lungs or in the veins.

CVS Pharmacy Patient Statistics for Eliquis: Oral tablet(2.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Eliquis 2.5mg Tablet

NDC: 000030893
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Deep Venous Thrombosis (DVT), Deep Venous Thrombosis (DVT) Prophylaxis, Atrial Fibrillation, Pulmonary Embolism Prophylaxis, Pulmonary Embolism, Stroke Prophylaxis

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Eliquis 2.5mg Tablet
Drug Image file DrugItem_17064.JPG
Bristol Myers Squibb Co
Pill Identification: 893  |  2 1/2
Shape: round
Color: yellow

Reported Side Effects for Eliquis 2.5mg Tablet

Melena Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Coughing Up Blood Incidence:
<1.2%*
Severity: MODERATE
Onset: DELAYED
Vomiting Of Blood Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Bleeding Within The Eye Incidence:
<0.2%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Blood In The Urine Incidence:
<2.1%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
<3.6%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Bleeding In The Brain Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
0.6-2.1%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
0.6-0.8%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
0.9-2.0%*
Severity: MODERATE
Onset: EARLY
Vaginal Bleeding Incidence:
1.1%*
Severity: MODERATE
Onset: DELAYED
Heavy Menstrual Period Incidence:
1.4%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
2.6%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Eliquis

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.